GlycoMimetics, Inc. (GLYC)
- Previous Close
0.2425 - Open
0.2507 - Bid --
- Ask 0.2444 x 300
- Day's Range
0.2377 - 0.2557 - 52 Week Range
0.1400 - 0.6300 - Volume
143,665 - Avg. Volume
1,459,945 - Market Cap (intraday)
15.496M - Beta (5Y Monthly) 1.70
- PE Ratio (TTM)
-- - EPS (TTM)
-0.5900 - Earnings Date May 8, 2025 - May 12, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
GlycoMimetics, Inc. engages in the discovery and development of therapies for cancers and inflammatory diseases in the United States. The company was founded in 2003 and is based in Monrovia, Maryland.
www.glycomimetics.comRecent News: GLYC
View MorePerformance Overview: GLYC
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GLYC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GLYC
View MoreValuation Measures
Market Cap
15.50M
Enterprise Value
4.84M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
2.92
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-72.04%
Return on Equity (ttm)
-173.25%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-37.88M
Diluted EPS (ttm)
-0.5900
Balance Sheet and Cash Flow
Total Cash (mrq)
10.72M
Total Debt/Equity (mrq)
1.26%
Levered Free Cash Flow (ttm)
-14.28M